C-6KXALadder Bio
Spiroligomer molecules, synthetic peptides, targeted drug discovery
small molecule
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-6KXA
C-6KXAC-6KXASpiroligomer molecules, synthetic peptides, targeted drug discovery
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Ladder Bio states that its Spiroligomer molecules are a novel synthetic chemical platform with modular fused-ring structures and diverse functional groups that give the company precise control over molecular shape. It says this enables the design of billions of unique compounds for highly selective protein binding and supports the view that Spiroligomer molecules can serve as effective therapeutics and diagnostics because they combine selectivity with stability, cell permeability, protease resistance, non-immunogenicity, potential oral bioavailability, affordability, and manufacturing consistency.
SourceLadder Bio states that its Spiroligomer molecules are a novel synthetic chemical platform that enables precise control over molecular shape and highly selective protein binding, making them well suited for targeted drug discovery and diagnostic testing. The company presents these molecules as stable, cell-permeable, protease-resistant, non-immunogenic, potentially orally bioavailable, and affordable to manufacture, with the added advantage of avoiding batch-to-batch variability seen in other modalities.
Source